Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Journal of Pharmacology and PharmacotherapeuticsNOW IN
    Article

    Fingolimod (FTY720): First approved oral therapy for multiple sclerosis

    Sushil Sharma1★, A G Mathur1, Sapna Pradhan1, D B Singh1, Sparsh Gupta1★ Corresponding author

    1. 1Department of Pharmacology, Army College of Medical Sciences, Delhi Cantt, New Delhi, India Molecules of the Millennium.

    CORRESPONDENCE

    Sushil Sharma

    Department of Pharmacology, Army College of Medical Sciences, Delhi Cantt, New Delhi, India Molecules of the Millennium.

    sushkehar@rediffmail.com

    Volume 2, Issue 1 · pp. 49–51 · PUBLISHED 2011 · DOI: 10.4103/0976-500X.77118

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    KEYWORDS

      Open in new tab

      REFERENCES

      As published

      Showing references and in-text citations exactly as published.

        Cite this article

        SELECT FORMAT

        Sharma, S., Mathur, A. G., Pradhan, S., Singh, D. B., & Gupta, S. (2011). Fingolimod (FTY720): First approved oral therapy for multiple sclerosis. Journal of Pharmacology and Pharmacotherapeutics, 2(1), 49–51. https://doi.org/10.4103/0976-500X.77118